Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong
· Delayed Price · Currency is HKD 14.86
+0.30 (2.06%)
Jun 27, 2025, 4:08 PM HKT
Medlive Technology Market Cap
Medlive Technology has a market cap or net worth of 12.49 billion as of June 27, 2025. Its market cap has increased by 125.15% in one year.
Market Cap
12.49B
Enterprise Value
8.15B
Revenue
594.29M
Ranking
n/a
PE Ratio
37.41
Stock Price
14.86
Market Cap Chart
Since July 15, 2021, Medlive Technology's market cap has decreased from 21.40B to 12.49B, a decrease of -41.63%. That is a compound annual growth rate of -12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 12.49B | 71.77% |
| Dec 31, 2024 | 7.27B | 17.93% |
| Dec 29, 2023 | 6.16B | 0.75% |
| Dec 30, 2022 | 6.12B | -68.46% |
| Dec 31, 2021 | 19.40B | -9.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 252.86B |
| Hansoh Pharmaceutical Group Company | 173.02B |
| JD Health International | 138.56B |
| Innovent Biologics | 127.75B |
| WuXi Biologics | 102.33B |
| Sino Biopharmaceutical | 94.79B |
| CSPC Pharmaceutical Group | 92.92B |
| Akeso | 83.03B |